AIM ImmunoTech

-$0.04 (-1.89%) Today
-$0.02 (-0.96%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AIM ImmunoTech and other stocks, options, and ETFs commission-free!

About AIM

AIM ImmunoTech Inc., also called AIM ImmunoTech, is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.

CEO
Thomas Kenwood Equels
Employees
23
Headquarters
Ocala, Florida
Founded
1966

AIM Key Statistics

Market Cap
101.35M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
353.17K
High Today
$2.13
Low Today
$2.06
Open Price
$2.13
Volume
392.77K
52 Week High
$4.30
52 Week Low
$1.60

AIM Earnings

-$1.13
-$0.74
-$0.36
$0.03
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, Pre-Market

You May Also Like

QTWO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure